ZA200108398B - Anti-HIV-1 vaccine comprising all or part of the HIV-1 Tat protein. - Google Patents

Anti-HIV-1 vaccine comprising all or part of the HIV-1 Tat protein.

Info

Publication number
ZA200108398B
ZA200108398B ZA200108398A ZA200108398A ZA200108398B ZA 200108398 B ZA200108398 B ZA 200108398B ZA 200108398 A ZA200108398 A ZA 200108398A ZA 200108398 A ZA200108398 A ZA 200108398A ZA 200108398 B ZA200108398 B ZA 200108398B
Authority
ZA
South Africa
Prior art keywords
hiv
vaccine
tat protein
tat
protein
Prior art date
Application number
ZA200108398A
Inventor
Erwann Loret
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Publication of ZA200108398B publication Critical patent/ZA200108398B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA200108398A 1999-04-13 2001-10-12 Anti-HIV-1 vaccine comprising all or part of the HIV-1 Tat protein. ZA200108398B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9904610A FR2792204B1 (en) 1999-04-13 1999-04-13 ANTI-HIV-1 VACCINE COMPRISING ANY PART OF THE HIV-1 TAT PROTEIN

Publications (1)

Publication Number Publication Date
ZA200108398B true ZA200108398B (en) 2002-09-25

Family

ID=9544341

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200108398A ZA200108398B (en) 1999-04-13 2001-10-12 Anti-HIV-1 vaccine comprising all or part of the HIV-1 Tat protein.

Country Status (2)

Country Link
FR (1) FR2792204B1 (en)
ZA (1) ZA200108398B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2834717B1 (en) * 2002-01-11 2004-12-10 Bio Merieux MUTANTS OF THE HIV-1 VIRUS TAT PROTEIN
KR100468316B1 (en) 2002-01-29 2005-01-27 주식회사 웰진 Peptides increasing the transfer efficiency of DNA into cell or tissue
WO2018085836A1 (en) * 2016-11-07 2018-05-11 Colorado State University Research Foundation Anti-hiv peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2700169B1 (en) * 1993-01-04 1995-03-24 Transgene Sa New TAT trans-dominant variants of the human immunodeficiency virus.

Also Published As

Publication number Publication date
FR2792204A1 (en) 2000-10-20
FR2792204B1 (en) 2001-07-13

Similar Documents

Publication Publication Date Title
ZA200107284B (en) Stable recombinant influenza viruses free of helper viruses.
DK1210113T3 (en) Combined vaccine preparations
IL136372A0 (en) Hiv-1 tat, or derivatives thereof, alone or in combination, for prophylactic and therapeutic vaccination against aids, tumor and related syndromes
IS5953A (en) Pharmaceutical preparations from microplated eplerenones
NL1015859A1 (en) Pharmaceutical preparations.
HK1077601A1 (en) Genetic vaccine against human immunodeficiency virus
IL150961A0 (en) Human immunodeficiency virus vaccine
HUP0200841A2 (en) Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein
AU2265701A (en) Anti-hiv-1 conjugates for treatment of hiv disease
MXPA01012478A (en) Improved pharmaceutical formulations.
GB9826069D0 (en) HIV vaccine
BR0000706B1 (en) disposable diaper.
BR0001216B1 (en) disposable diaper.
NO20016247D0 (en) Streptogramin derivatives, their preparation and preparations containing the derivatives
NO20020156D0 (en) Titanium derived compounds, their preparation and their use
HK1046428A1 (en) The genome of the hiv-1 inter-subtype (c/b') and use thereof
DE60029273D1 (en) Titanium Tinoxidfilme
ZA200108398B (en) Anti-HIV-1 vaccine comprising all or part of the HIV-1 Tat protein.
GB2349150B (en) Expression of DNA or proteins in C. Elegans
ES1044251Y (en) DENTAL IMPLANT.
MXPA01010701A (en) Vaccine.
AU2960000A (en) Detection of human immunodeficiency virus
AU6896300A (en) Vaccines for the treatment of autoimmune disease
DK1105498T3 (en) HIV vaccine
AU8096998A (en) Attenuated human immunodeficiency virus vaccine